|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 |
| (11) | Number of the document | 3062815 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14802175.1 |
| Date of filing the European patent application | 2014-10-17 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/065419 |
| Date | 2014-10-17 |
| (87) | Number | WO 2015/063647 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361898966 P | 2013-11-01 | US |
| (72) |
BINDER, Joseph John, US
CHO, Helen Kim, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | VECTORS FOR EXPRESSION OF PROSTATE-ASSOCIATED ANTIGENS |
| VECTORS FOR EXPRESSION OF PROSTATE-ASSOCIATED ANTIGENS |